• Return to Headlines

Akebia Therapeut Has Returned 20.1% Since SmarTrend Recommendation (AKBA)

By James Quinn

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on November 9th, 2017 at $15.76. In approximately 4 months, Akebia Therapeut has returned 20.11% as of today's recent price of $12.59.

Akebia Therapeut share prices have moved between a 52-week high of $20.25 and a 52-week low of $7.00 and are now trading 80% above that low price at $12.59 per share. Over the past week, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has advanced 1.5%.

Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Akebia Therapeut.

Log in and add Akebia Therapeut (AKBA) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights akebia therapeut

Ticker(s): AKBA